Department of Biomedicine
Biozentrum U1.141
Dr. Derya Shimshek, Novartis Pharma AG
The choice of amyloidosis mousemodel dictates the effect of Trem2 microglia activation by cell surface stabilization
Export event as iCal
Back
Social Media